Liposomes - Advances and Perspectives 2019
DOI: 10.5772/intechopen.84255
|View full text |Cite
|
Sign up to set email alerts
|

General Perception of Liposomes: Formation, Manufacturing and Applications

Abstract: Liposomes are currently part of the most reputed carriers for various molecular species, from small and simple to large and complex molecules. Since their discovery, liposomes have been subject to extensive evolution, in terms of composition, manufacturing and applications, which led to several openings in both basic and applied life sciences. However, most of the advances in liposome research have been more devoted to launching new developments than improving the existing technology for potential implementati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 70 publications
0
30
0
5
Order By: Relevance
“…Tehnologija inkapsulacije nameće se kao jedno od rešenja kojim bi se prevazišli navedeni nedostaci i poboljšala primena peptida soje, kako u prehrambenim, tako i u farmaceutskim formulacijama. Danas, nekoliko tehnika smatra se relevantnim, a istovremeno su i najzastupljenije, za inkapsulaciju proteinskih hidrolizata i peptida: 1) hidriranje lipidnog filma (priprema lipozoma i liposfera), 2) sprej sušenje (priprema mikrosfera na bazi polisaharida i proteina) i 3) koacervacija (priprema koacervata sa hidrofilnim omotačem) [10,11]. Lipozomi i liposfere predstavljaju konvencionalne nosače za inkapsulaciju proteinskih hidrolizata i peptida.…”
Section: Introductionunclassified
See 1 more Smart Citation
“…Tehnologija inkapsulacije nameće se kao jedno od rešenja kojim bi se prevazišli navedeni nedostaci i poboljšala primena peptida soje, kako u prehrambenim, tako i u farmaceutskim formulacijama. Danas, nekoliko tehnika smatra se relevantnim, a istovremeno su i najzastupljenije, za inkapsulaciju proteinskih hidrolizata i peptida: 1) hidriranje lipidnog filma (priprema lipozoma i liposfera), 2) sprej sušenje (priprema mikrosfera na bazi polisaharida i proteina) i 3) koacervacija (priprema koacervata sa hidrofilnim omotačem) [10,11]. Lipozomi i liposfere predstavljaju konvencionalne nosače za inkapsulaciju proteinskih hidrolizata i peptida.…”
Section: Introductionunclassified
“…Nedostaci lipozoma kao nosača za inkapsulaciju proizilaze od njihove loše stabilnosti usled oksidacije i hidrolize lipida, cepanja i fuzije koloidnih čestica, i posledičnog gubitka hidrofilnog jezgra. Navedeni nedostaci uspešno se prevazilaze dodavanjem stabilizatora, antioksidanata i post-preparativnim postupcima kao što je zamrzavanje [10,11].…”
Section: Introductionunclassified
“…Reduced use of solvents compared to the traditional evaporation methods is the main attraction of supercritical fluid methods. However, several disadvantages of this techniques particularly involvement of high cost and pressure, usage of sophisticated instruments have been documented (Nkanga et al, 2019). Two main types of supercritical fluid technology-based liposome preparation are employed in the preparation of liposomes including (1) the supercritical antisolvent (SAS) method and (2) the supercritical reverse-phase evaporation (SRPE) method (Chakravarty et al, 2019).…”
Section: Supercritical Fluidic Methodsmentioning
confidence: 99%
“…If the BAC is of a lipophilic nature, solvent may be added and subsequently dried. On other hand, if the BAC is of a hydrophilic nature, it might be incorporated to the dried lipids during hydration with aqueous phase (Alavi et al, 2017;Nkanga et al, 2019).…”
Section: Drying Of Lipids Dissolved In Organic Solventmentioning
confidence: 99%
“…The main hurdle to nanotechnology, particularly conventional liposome use, is the in vivo recognition and clearance by the MPS of the host [ 206 ]. This biological fate suggests these may be suitable delivery systems for the passive targeting of diseases where the target is located inside MPS cells such as leishmaniasis and tuberculosis as any decrease the circulation half-life of nanoparticles may lead to therapeutic failure when the target site of action is external to the MPS [ 223 ].…”
Section: Biocompatibility Of Biomaterials Used For Nanoencapsulatimentioning
confidence: 99%